{"id":6485,"date":"2024-06-03T08:00:58","date_gmt":"2024-06-03T06:00:58","guid":{"rendered":"https:\/\/www.medincell.com\/?p=6485"},"modified":"2024-08-01T14:48:25","modified_gmt":"2024-08-01T12:48:25","slug":"le-partenaire-de-medincell-teva-a-presente-de-nouvelles-donnees-soutenant-le-passage-dinvega-sustenna-palmitate-de-paliperidone-a-uzedy-pour-le-traitement-de-la-schizophrenie","status":"publish","type":"post","link":"https:\/\/www.medincell.com\/fr\/le-partenaire-de-medincell-teva-a-presente-de-nouvelles-donnees-soutenant-le-passage-dinvega-sustenna-palmitate-de-paliperidone-a-uzedy-pour-le-traitement-de-la-schizophrenie\/","title":{"rendered":"Le partenaire de Medincell, Teva, a pr\u00e9sent\u00e9 de nouvelles donn\u00e9es soutenant le passage d\u2019Invega Sustenna\u00ae (palmitate de palip\u00e9ridone) \u00e0 UZEDY\u00ae pour le traitement de la schizophr\u00e9nie"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"link","meta":{"_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"0","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"","_seopress_redirections_param":"","_seopress_redirections_type":0,"_seopress_analysis_target_kw":"","_seopress_news_disabled":"","_seopress_video_disabled":"","_seopress_video":[],"_seopress_pro_schemas_manual":[],"_seopress_pro_rich_snippets_disable_all":"","_seopress_pro_rich_snippets_disable":[],"_seopress_pro_schemas":[],"itsec_x_frame_options":"","footnotes":""},"categories":[37,38,39,29,43],"tags":[40],"class_list":["post-6485","post","type-post","status-publish","format-link","category-home-fr","category-investors-fr","category-news-fr","category-non-classifiee","category-uzedy-fr","tag-2024-fr","post_format-post-format-link"],"_links":{"self":[{"href":"https:\/\/www.medincell.com\/fr\/wp-json\/wp\/v2\/posts\/6485","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.medincell.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.medincell.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.medincell.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.medincell.com\/fr\/wp-json\/wp\/v2\/comments?post=6485"}],"version-history":[{"count":1,"href":"https:\/\/www.medincell.com\/fr\/wp-json\/wp\/v2\/posts\/6485\/revisions"}],"predecessor-version":[{"id":6686,"href":"https:\/\/www.medincell.com\/fr\/wp-json\/wp\/v2\/posts\/6485\/revisions\/6686"}],"wp:attachment":[{"href":"https:\/\/www.medincell.com\/fr\/wp-json\/wp\/v2\/media?parent=6485"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.medincell.com\/fr\/wp-json\/wp\/v2\/categories?post=6485"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.medincell.com\/fr\/wp-json\/wp\/v2\/tags?post=6485"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}